Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc supplementation in chronic hemodialysis patients
IRCT138902033777N1Phase 3Completed
- Sponsor
- Drug Applied Research Center
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zinc in end-stage kidney disease (ESKD), sponsored by Drug Applied Research Center. Started Oct 2003; status: completed.
02
Drugs
zinc
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT138902033777N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138902033777N1.